Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Norman P. Gould is active.

Publication


Featured researches published by Norman P. Gould.


Archive | 1990

Potent and Selective Oxytocin Antagonists Obtained by Chemical Modification of a Streptomyces Silvensis Derived Cyclic Hexapeptide and by Total Synthesis

Mark G. Bock; Robert M. DiPardo; Peter D. Williams; R. D. Tung; J. M. Erb; Norman P. Gould; Willie L. Whitter; Debra S. Perlow; George F. Lundell; Richard G. Ball; Douglas J. Pettibone; B. V. Clineschmidt; Daniel F. Veber; Roger M. Freidinger

Oxytocin (OT) is a neurohypophyseal hormone which has an important function in parturition.1 There is considerable evidence that the uterotonic action of OT and its stimulation of uterine prostaglandin release combine to initiate labor.2,3 Additionally, OT mediates the postpartum function of contracting the mammary myoepithelium to elicit milk letdown4 and has also recently been implicated as a key element in preterm labor.5,6 Attempts to further delineate these OT connected events have provided the impetus to discover agents which interact selectively and competitively at the OT receptor. Such compounds are invaluable in determining the physiological and pathophysiological role of OT and its close structurally related hormone, arginine vasopressin (AVP). Additional interest derives from the prospect of their use as novel therapeutic agents.


Journal of Medicinal Chemistry | 1992

Orally active, nonpeptide oxytocin antagonists

Ben E. Evans; James L. Leighton; Kenneth E. Rittle; Kevin F. Gilbert; George F. Lundell; Norman P. Gould; Doug W. Hobbs; Robert M. DiPardo; Daniel F. Veber; Douglas J. Pettibone; Bradley V. Clineschmidt; Paul S. Anderson; Roger M. Freidinger


Journal of Medicinal Chemistry | 1986

Agents for the treatment of brain edema. 2. [(2,3,9,9a-Tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]+ ++alkanoi c acids and some of their analogues.

Edward J. Cragoe; Woltersdorf Ow; Norman P. Gould; Adolph M. Pietruszkiewicz; Ziegler C; Sakurai Y; Stokker Ge; Paul S. Anderson; Bourke Rs; Kimelberg Hk


Journal of Organic Chemistry | 1992

Use of N-Fmoc amino acid chlorides and activated 2-(fluorenylmethoxy)-5(4H)-oxazolones in solid-phase peptide synthesis. Efficient syntheses of highly N-alkylated cyclic hexapeptide oxytocin antagonists related to L-365,209

Debra S. Perlow; Jill M. Erb; Norman P. Gould; Roger D. Tung; Roger M. Freidinger; Peter D. Williams; Daniel F. Veber


Archive | 1981

[(5,6,9a-Substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acids, their analogs, esters, salts, and derivatives

Edward J. Cragoe; Gerald E. Stokker; Norman P. Gould


Journal of Medicinal Chemistry | 1992

Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product

Peter D. Williams; Mark G. Bock; Tung Rd; Garsky Vm; Debra S. Perlow; Jill M. Erb; George F. Lundell; Norman P. Gould; Willie L. Whitter; Hoffman Jb


Journal of Medicinal Chemistry | 1977

Prostaglandin isosteres. 1. (8-Aza-, 8,10-diaza-, and 8-aza-11-thia)-9-oxoprostanoic acids and their derivatives

Robert L. Smith; Ta-Jyh Lee; Norman P. Gould; Edward J. Cragoe


Archive | 1981

[(5,6,9a-substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acid esters and their analogs, the parent acids and their salts

Edward J. Cragoe; Gerald E. Stokker; Norman P. Gould


Journal of Medicinal Chemistry | 1990

Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications

Roger M. Freidinger; Peter D. Williams; Tung Rd; Mark G. Bock; Douglas J. Pettibone; Bradley V. Clineschmidt; Robert M. DiPardo; Jill M. Erb; Garsky Vm; Norman P. Gould


Archive | 1968

CERTAIN HALOPHENOXY ALKANAMIDES, HYDRAZIDES AND DERIVATIVES THEREOF

Edward J. Cragoe; Norman P. Gould

Researchain Logo
Decentralizing Knowledge